A helminth-derived suppressor of ST2 blocks allergic responses.

HpBARI administered at day 0 was able to suppress BAL and lung eosinophilia, and ILC2 and CD4+ T cell IL-13 production, although in the case of ILC2 IL-13 production this did not reach statistical significance ( Figure 4A–D ).

also in 111,027 other papers